Singulair and Varenicline tartrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Singulair and Varenicline tartrate. Common interactions include drug ineffective among females and breath sounds among males.

The phase IV clinical study analyzes what interactions people who take Singulair and Varenicline tartrate have. It is created by eHealthMe based on reports of 21 people who take Singulair and Varenicline tartrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

21 people who take Singulair and Varenicline tartrate together, and have interactions are studied.


What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 115,306 Singulair users for its effectiveness, alternative drugs and more.

What is Varenicline tartrate?

Varenicline tartrate has active ingredients of varenicline tartrate. eHealthMe is studying from 3,358 Varenicline tartrate users for its effectiveness, alternative drugs and more.

Number of Singulair and Varenicline tartrate reports submitted per year:

Singulair and Varenicline tartrate drug interactions.

Common Singulair and Varenicline Tartrate drug interactions by gender *:

female:

  1. Drug ineffective
  2. Cough
  3. Wheezing
  4. Agitation
  5. Anger
  6. Blood pressure increased
  7. Chest discomfort
  8. Dyspnoea exertional
  9. Hypomania
  10. Irritability

male:

  1. Breath sounds
  2. Bronchial hyperreactivity
  3. Bronchitis
  4. Cardiac disorder
  5. Cardiomyopathy
  6. Drug ineffective
  7. Drug intolerance
  8. Dyspnoea
  9. Eosinophilia
  10. Ischaemic cardiomyopathy

Common Singulair and Varenicline Tartrate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Agitation
  2. Anger
  3. Hypomania
  4. Irritability
  5. Suicidal behaviour
  6. Aggression
  7. Crying
  8. Depression
  9. Flight of ideas
  10. Formication

50-59:

  1. Cough
  2. Drug ineffective
  3. Wheezing
  4. Blood pressure increased
  5. Chest discomfort
  6. Dyspnoea exertional
  7. Palpitations
  8. Arrhythmia
  9. Bronchitis
  10. Dyspnoea

60+:

  1. Breath sounds
  2. Bronchial hyperreactivity
  3. Bronchitis
  4. Cardiac disorder
  5. Cardiomyopathy
  6. Drug ineffective
  7. Drug intolerance
  8. Dyspnoea
  9. Eosinophilia
  10. Ischaemic cardiomyopathy

Common conditions people have *:

  1. Cough: 3 people, 14.29%
  2. Insomnia (sleeplessness): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Singulair and Varenicline tartrate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Singulair and Varenicline tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Singulair interactions:

Browse all interactions between Singulair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Varenicline tartrate interactions:

Browse all interactions between Varenicline tartrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium and varenicline tartrate (the active ingredients of Singulair and Varenicline tartrate, respectively), and Singulair and Varenicline tartrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Singulair and Varenicline tartrate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: